Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Bone Miner Res. 2019 Dec 27;35(4):714–724. doi: 10.1002/jbmr.3930

Figure 1: PTH (1-34) and abaloparatide improved bone mineral density whereas PTHrP (1-36) had no effect in mice.

Figure 1:

A) Mouse body length at the end of the treatments. B-D) Throughout the course of the study, DEXA-Piximus was performed every 2 weeks to measure bone mineral density (BMD) of B) whole body, C) femur and D) tibia. Ten mice per group. Results are means ± SD. All data were analyzed for normality and equivalence of variance before a 2 way ANOVA – repeated measures followed by Bonferroni’s multiple comparison test. All exact p values are indicated in Fig. 1A. In Figs. 1B-D, the p values at one time point compare the peptides to the vehicle controls. The p values on the lines compare one peptide at the two connected time points.